Invasive aspergillosis (IA) usually occurs in immunocompromised hosts, but in the last decade IA has emerged in critically ill non-neutropenic patients, as those with severe Influenza and Chronic Obstructive Pulmonary Disease (COPD). We report an unusual fatal case of disseminated IA in a non-immunocompromised patient following yellow fever vaccine-associated viscerotropic disease.
Background: Syphilis is an endemic disease, particularly in low- and middle-income countries, with vascular involvement in large vessels (aortitis), but no clear relationship with stroke patients, except for those who presented with meningovascular neurosyphilis. Objective: To investigate the relationship between a positive history of syphilis determined by serological testing and ischemic stroke etiology, particularly small vessel disease (SVD). Methods: In total, 269 first-ever ischemic stroke patients admitted to the stroke unit were tested for syphilis. Patients with neurosyphilis were excluded. All patients were classified according to the ASCOD phenotyping as SVD — when SVD was the potential causal mechanism (S1) — or non-SVD — when SVD was uncertain (S2), unlike (S3), or not detected (S0). Results: Syphilis was positive in 32 (12%) patients. When comparing patients with positive and negative serology, the only significant difference was SVD as the causal mechanism (S1) in patients with positive results: 9 (28%) vs. 22 (9%), p<0.01. Conclusion: The current study showed that the frequency of positive syphilis serological test was higher in patients with first-ever ischemic stroke and SVD as the potential causal mechanism. This finding could be related to the endothelial dysfunction occurring in syphilis.
10 February 2022 in The Brazilian Journal of Infectious Diseases
Immune reconstitution inflammatory syndrome (IRIS) is a potentially severe complication following the withdrawal of immunosuppressive agents, commonly studied in human immunodeficiency virus (HIV) positive patients. However, its impact on individuals with hematological malignancies and those undergoing hematopoietic stem cell transplants is less understood. This study aimed to establish diagnostic criteria for IRIS in these populations and assess its incidence and clinical progression. A cross-sectional, prospective observational study was conducted with 159 chemotherapy patients and 96 hematopoietic stem cell transplant recipients. IRIS diagnosis criteria were derived from a literature review of 70 studies, and patients were monitored for 11 months. The review identified key IRIS diagnostic criteria, including paradoxical clinical worsening, antimicrobial refractoriness, and inflammatory signs following immunosuppressive therapy. Most IRIS cases were linked to pathogens like Mycobacterium, Candida spp., and Aspergillus spp. Among our patients, three cases of IRIS were identified: one related to the Bacillus Calmette-Guérin (BCG) vaccine, another with neutrophil recovery, and the third with chronic disseminated candidiasis. Treatment with corticosteroids and antimicrobial therapy allowed continued chemotherapy without impacting the underlying disease’s outcomes. IRIS is an important complication in hematological and stem cell transplant patients. Early recognition and appropriate treatment, including corticosteroids and antimicrobial therapy, are critical for successful management and uninterrupted cancer treatment.
Cryptococcus gattii complex has emerged as an important cause of invasive fungal disease in both immunocompetent and immunocompromised hosts, yet robust clinical and epidemiological data remain limited, particularly in Latin America. An observational study was conducted to describe and analyze the clinical characteristics and outcomes of all proven and probable cases of C. gattii complex infection managed at a tertiary referral center in southern Brazil from 1992–2025. A total of 39 cases were identified. The median age was 54 years, and 61.5% were male. Most patients (61.5%) were considered immunocompetent, although comorbidities were common. Headache (61.5%), altered mental status (33.3%), and fever (30.8%) were the most frequent symptoms overall. Pulmonary disease was the predominant clinical form (76.9%), but meningitis/meningoencephalitis was also common (69.2%). Nearly half (46.2%) had both pulmonary and neurological disease. Cryptococcomas were frequent (76.9%); the majority were managed without surgical intervention. Severe impairment of consciousness at presentation and cerebrospinal fluid protein levels above 92.15 mg/dL were significantly associated with mortality. Amphotericin B (AmB) deoxycholate plus fluconazole was the most prescribed induction regimen, with a median duration of 3 weeks. The overall mortality was 20.5%. Immune reconstitution inflammatory syndrome (IRIS) occurred only among patients with cryptococcomas and was managed with glucocorticoids in most cases. The performance of the cryptococcal antigen test (CrAg) was excellent in both neurological and pulmonary diseases. This study highlights the clinical spectrum of C. gattii complex infection and supports the potential utility of shorter induction regimens (< 4 weeks), as well as the role of CrAg as a valuable diagnostic tool.